Physician profile
Ans Dastgir
NPI 1457926826
$283.35
in general payments reported to CMS, 2019-2025
10 companies · $210 in 2025
The $210 reported for 2025 was more than what 77% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $73.61 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $64.56 | 2025 | |
| Janssen Pharmaceuticals, INC | $36.17 | 2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $35.92 | 2025 | Assure Wcd |
| Ceribell, INC. | $34.11 | 2025 | Pocket Eeg Device |
| Merck Sharp & Dohme LLC | $23.90 | 2024 | Recarbrio, Dificid, Zerbaxa |
| Ucb, INC. | $20.52 | 2025 | Briviact |
| Amgen INC. | $19.32 | 2025 | Uplizna |
| Scpharmaceuticals INC. | $18.09 | 2025 | |
| Novo Nordisk INC | $17.22 | 2025 | Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $13.54 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ans Dastgir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.